AI assistant
INSMED Inc — Director's Dealing 2020
Aug 12, 2020
30150_dirs_2020-08-12_ff02b5da-03d4-4977-a191-a15a66872cd1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2020-05-15
Reporting Person: SORIANO JOHN (Chief Compliance Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-15 | Common Stock | F | 994 | $25.46 | Disposed | 78253 | Direct |
| 2020-08-10 | Common Stock | M | 52046 | $13.91 | Acquired | 77259 | Direct |
| 2020-08-10 | Common Stock | S | 52046 | $30.29 | Disposed | 25213 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-08-10 | Stock Option (right to buy) | $13.91 | M | 52046 | Disposed | 2029-01-03 | Common Stock (52046) | Direct |
Footnotes
F1: Represents the withholding of shares of common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. This transaction was not reported previously due to a clerical error.
F2: This is the weighted average sales price representing 52,046 shares sold at prices ranging from $30.12 to $30.49 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.